AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Regulatory Filings Aug 5, 2022

2543_rns_2022-08-05_fdcfce5d-58d5-4ea7-b534-25cb8e5dba1d.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Current report №67/ 2022 Dated August 5, 2022

NOTIFICATION

"Sopharma" AD (the Company) notifies that for July 2022 the Company recorded an increase in sales of 146% compared to the same month of the previous year, incl. 96% increase in domestic sales and 206% increase in export sales.

For the seven months since the beginning of the year the revenues from sales of products increase by 46%, incl. 42% increase of sales for the domestic market and 49% increase in export sales.

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.